|
TTC7B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.171500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.307000E-01 |
| Normal-vs-Stage2 |
6.929700E-02 |
| Normal-vs-Stage3 |
1.633380E-04 |
| Normal-vs-Stage4 |
8.235500E-03 |
| Stage1-vs-Stage2 |
2.262000E-02 |
| Stage1-vs-Stage3 |
3.55820000019769E-07 |
| Stage1-vs-Stage4 |
5.182800E-04 |
| Stage2-vs-Stage3 |
4.830200E-01 |
| Stage2-vs-Stage4 |
4.964000E-01 |
| Stage3-vs-Stage4 |
8.344600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.559500E-02 |
| Normal-vs-AfricanAmerican |
3.627600E-01 |
| Normal-vs-Asian |
9.491400E-01 |
| Caucasian-vs-AfricanAmerican |
8.909600E-02 |
| Caucasian-vs-Asian |
5.899200E-01 |
| AfricanAmerican-vs-Asian |
7.068000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.918300E-03 |
| Normal-vs-Female |
6.147600E-01 |
| Male-vs-Female |
1.680540E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.053800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.054000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.757000E-03 |
| Normal-vs-Age(81-100Yrs) |
5.897600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.069600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.902100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.192500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.118400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.287790E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.790200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.186390E-02 |
| Normal-vs-Grade 2 |
5.054600E-01 |
| Normal-vs-Grade 3 |
9.423800E-03 |
| Normal-vs-Grade 4 |
4.49139999969539E-07 |
| Grade 1-vs-Grade 2 |
4.379300E-03 |
| Grade 1-vs-Grade 3 |
1.303820E-03 |
| Grade 1-vs-Grade 4 |
9.32120003405146E-09 |
| Grade 2-vs-Grade 3 |
6.550600E-04 |
| Grade 2-vs-Grade 4 |
1.84339998821059E-09 |
| Grade 3-vs-Grade 4 |
2.273800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.772600E-01 |
| Normal-vs-ccB subtype |
9.500200E-02 |
| ccA subtype-vs-ccB subtype |
5.010200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.201020E-01 |
| Normal-vs-N1 |
4.24030000000242E-05 |
| N0-vs-N1 |
5.365500E-04 |
|
|
